Author | Data range | Country | Design | TINU cases/ population(n) | TINU cases (%) |
---|---|---|---|---|---|
‘All-age’ Studies with >500 patients | |||||
Rodriguez [47] | 1982–1992 | USA | Retrospective | 0/1237 | 0 |
Rothova [48] | 1984–1989 | The Netherlands | Retrospective | 0/865 | 0 |
Mackensen [7]* | 1985–2005 | USA | Retrospective | 33/1985 | 1.66 |
Mercanti [49] | 1986–1993 | Italy | Retrospective | 0/655 | 0 |
Oruc [50] | 1990–1995 | USA | Retrospective | 0/853 | 0 |
Tran [51] | 1990–1993 | Switzerland | Prospective | 0/558 | 0 |
Jones [9] | 1991–2013 | UK | Prospective | 7/3000 | 0.23 |
Kotake [52] | 1994 | Japan | Retrospective | 4/551 | 0.73 |
Barisani-Asenbauer [53] | 1995–2009 | Austria | Retrospective | 0/2619 | 0 |
Rathinam [54] | 1996–2001 | India | Retrospective | 0/8759 | 0 |
Singh [55] | 1996–2001 | India | Retrospective | 0/1233 | 0 |
Yang [56] | 1996–2003 | China | Retrospective | 0/1752 | 0 |
Soheilian [57] | 1997–2000 | Iran | Retrospective | 0/544 | 0 |
Jakob [12] | 2001–2006 | Germany | Retrospective | 10/1916 | 0.52 |
Al Dhibi [58] | 2001–2010 | Saudi Arabia | Retrospective | 0/888 | 0 |
Kazokoglu [59] | 2004 | Turkey | Prospective | 0/761 | 0 |
Ohguro [8] | 2009–2010 | Japan | Prospective | 15/3830 | 0.39 |
Gonzalez Fernandez [60] | 2012–2013 | Brazil | Prospective | 0/1053 | 0 |
Total | Â | Â | Â | 69/33059 | 0.21 |
Paediatric Studies with >250 patients | |||||
Smith [61] | 1980–2005 | USA | Retrospective | 12/527 | 2.28 |
Kump [4] | 1985–2003 | USA | Retrospective | 3/269 | 1.12 |
BenEzra [62] | 1989–1999 | Israel | Retrospective | 4/275 | 1.45 |
Paroli [63] | 1995–2004 | Italy | Retrospective | 4/257 | 1.55 |
Total | Â | Â | Â | 23/1328 | 1.73 |